Buparlisib is a brain penetrable pan-PI3K inhibitor
Mark C. de Gooijer(Manchester Academic Health Science Centre), Olaf van Tellingen(The Netherlands Cancer Institute)
Cited by 80
Related Papers
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
|Clinical Cancer Research|2020|63
ATP-binding cassette transporters restrict drug delivery and efficacy against brain tumors even when blood-brain barrier integrity is lost
|Cell Reports Medicine|2021|59
MELK Inhibition in Diffuse Intrinsic Pontine Glioma
|Clinical Cancer Research|2018|45
Acquired and intrinsic resistance to vemurafenib in <scp> BRAF <sup>V600E</sup> </scp> ‐driven melanoma brain metastases
|FEBS Open Bio|2023|2
Acquired and intrinsic resistance to vemurafenib in BRAF <sup>V600E</sup> -driven melanoma brain metastases
|bioRxiv (Cold Spring Harbor Laboratory)|2022|0